Jan 28 (Reuters) - Ethos Technologies and some of its shareholders raised about $200 million in a U.S. initial public offering, the insurance platform said on Wednesday. The company and the selling ...

Ethos Technologies has priced its initial public offering and the expectation is that it will go public next Thursday, making it one of the first tech IPOs of the year. If it lands in its current ...

London‑listed PRTech firm Pathos Communications has developed its proprietary AI platform, PathosMind. Designed exclusively for use by Pathos employees and partners, it surfaces stories that genuinely ...

A British marketing agency ranked among Europe's fastest-growing businesses is planning to float on the London Stock Exchange later this month, The Mail on Sunday understands. Pathos Communications, ...

Warriors need critical skills that make them “competent, qualified, agile, professional, aggressive, innovative, risk-taking, apolitical,” Secretary Hegseth told senior officers last month. He could ...

GameSpot may get a commission from retail offers. 2K Games hasn't said much about its free-to-play third-person shooter currently in the works under the working title Project Ethos, but the game is ...

Ethos Technologies Inc. (LIFE) has filed to raise $100 million in an IPO of its Class A common stock, according to SEC S-1 registration information. LIFE provides a life insurance marketplace for ...

Sept 26 (Reuters) - Ethos Technologies recorded a 55% jump in revenue in the first half of 2025, according to its U.S. initial public offering paperwork filed on Friday, as the insurance IPO market ...

Secretary of Defense Pete Hegseth’s surprise gathering of hundreds of generals and admirals in Virginia next week is being called so he can describe the administration’s reinvention of the Department ...

One of Oklahoma’s most respected architecture firms is entering a new chapter. After more than three decades serving communities across the state, KKT Architects has officially rebranded as Ethos ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...